ViiV Healthcare to present data from largest head-to-head randomised trial for 2-drug regimen Dovato against 3-drug regimen Biktarvy at AIDS 2024

Source :: PharmaBiz. July 17, 2024
Publication Year :: 2024
Abstract: GSK plc announced that ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, will be presenting the largest head-to-head, randomised clinical trial [...]

Subjects :: Pfizer Inc. -- Product development
Rilpivirine -- Product development -- Research
Health care industry -- Product development
Clinical trials -- Research
AIDS treatment -- Research
AIDS (Disease) -- Research -- Drug therapy -- Prevention
International relief -- United States
Pharmaceutical industry -- Product development
Health care industry
Pharmaceuticals and cosmetics industries
Biktarvy (Medication) -- Research -- Product development
Dovato (Medication) -- Research -- Product development

Tools